Completed
Which outcomes or types of evidence matter? May vary by stakeholder type
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Cost and Coverage in Genomic Testing Medicine - Economic Perspectives
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Which outcomes or types of evidence matter? May vary by stakeholder type
- 3 Economic evaluation methods . Cost-effectiveness analysis (CEA)
- 4 Which economic evaluation method to use? • Payers may prefer budgetary impact analysis
- 5 What is a QALY? . Summary measure of population health
- 6 Cost-effectiveness . How to assess cost-effectiveness or cost savings - Comparison of two strategies
- 7 Modeling uncertainty in parameters • One-way sensitivity analyses - Parameters have specified range and distribution of estimates - Model is run using extreme estimates for each parameter leaving all
- 8 Medicare coverage of genomic tests and counseling . Genetic testing and counseling can be paid by Medicare for persons with certain diseases, based on medical necessity
- 9 Medicare and genetic testing for hereditary cancers: hereditary breast and ovarian cancer
- 10 Is genetic testing for hereditary cancers cost-effective? • Tumor testing for Lynch syndrome - In newly diagnosed patients with colorectal cancer (CRC) followed by
